Yi Q - Search Results

1

Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.

Xu Z, Zhou H, Li T, Yi Q, Thakur A, Zhang K, Ma X, Qin JJ, Yan Y. Xu Z, et al. Among authors: yi q. Drug Resist Updat. 2024 Jul;75:101098. doi: 10.1016/j.drup.2024.101098. Epub 2024 Jun 1. Drug Resist Updat. 2024. PMID: 38833804 Review.

2

Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment.

Yi Q, Xu Z, Thakur A, Zhang K, Liang Q, Liu Y, Yan Y. Yi Q, et al. Pharmacol Res. 2023 Apr;190:106733. doi: 10.1016/j.phrs.2023.106733. Epub 2023 Mar 15. Pharmacol Res. 2023. PMID: 36931541 Free article. Review.

3

Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration.

Yan Y, Liang Q, Xu Z, Yi Q. Yan Y, et al. Among authors: yi q. PeerJ. 2021 Sep 15;9:e12171. doi: 10.7717/peerj.12171. eCollection 2021. PeerJ. 2021. PMID: 34616622 Free PMC article.

4

MTHFR inhibits TRC8-mediated HMOX1 ubiquitination and regulates ferroptosis in ovarian cancer.

Wang X, Xu Z, Ren X, Chen X, Yi Q, Zeng S, Thakur A, Gong Z, Yan Y. Wang X, et al. Among authors: yi q. Clin Transl Med. 2022 Sep;12(9):e1013. doi: 10.1002/ctm2.1013. Clin Transl Med. 2022. PMID: 36149747 Free PMC article. No abstract available.

5

CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.

Zeng S, Chen XI, Yi Q, Thakur A, Yang H, Yan Y, Liu S. Zeng S, et al. Among authors: yi q. Oncol Res. 2023 Dec 28;32(2):261-272. doi: 10.32604/or.2023.042345. eCollection 2023. Oncol Res. 2023. PMID: 38186580 Free PMC article.

6

Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor.

Chen X, Yan Y, Liu Y, Yi Q, Xu Z. Chen X, et al. Among authors: yi q. J Nat Prod. 2024 Apr 26;87(4):837-848. doi: 10.1021/acs.jnatprod.3c01056. Epub 2024 Feb 28. J Nat Prod. 2024. PMID: 38417401

7

Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer.

Chen X, Yan Y, Liu Y, Yi Q, Xu Z. Chen X, et al. Among authors: yi q. Pharm Biol. 2024 Dec;62(1):394-403. doi: 10.1080/13880209.2024.2351934. Epub 2024 May 13. Pharm Biol. 2024. PMID: 38739003 Free PMC article.

8

Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma.

Yi Q, Liang Q, Liu Y, Gong Z, Yan Y. Yi Q, et al. Front Oncol. 2022 Oct 5;12:998736. doi: 10.3389/fonc.2022.998736. eCollection 2022. Front Oncol. 2022. PMID: 36276119 Free PMC article.

9

Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis.

Yan Y, Zhou S, Chen X, Yi Q, Feng S, Zhao Z, Liu Y, Liang Q, Xu Z, Li Z, Sun L. Yan Y, et al. Among authors: yi q. Signal Transduct Target Ther. 2024 Mar 4;9(1):58. doi: 10.1038/s41392-024-01763-x. Signal Transduct Target Ther. 2024. PMID: 38438346 Free PMC article.

10

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.

Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, Gao K, Wang X, Yi Q, Gong Z, Yan Y. Xu Z, et al. Among authors: yi q. Front Immunol. 2021 Sep 17;12:719175. doi: 10.3389/fimmu.2021.719175. eCollection 2021. Front Immunol. 2021. PMID: 34603293 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,725 results

Search Page

Filters